ArticleBMC cancer2026

Comparative prognostic performance of the REBECCA score and the Tabernero classification in refractory metastatic colorectal cancer treated with regorafenib: a multicenter real-world study.

Nieves Martínez-Lago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.